Extensive Clinical and Competitive Evaluation Leads Major California University Hospital System to Standardize on Senzime’s TetraGraph System
Uppsala, Sweden – Sept 4, 2025 – Senzime AB (publ) today announced that one more leading university-based hospital system in California has selected Senzime’s TetraGraph® as its standard of care for neuromuscular monitoring. The agreement includes an initial order of 35 TetraGraph systems that will be deployed across the system’s operating rooms, supporting safe anesthesia management for more than 10,000 surgical patients annually.
“It’s a highly strategic win when one of California’s most prominent university hospital systems choose to standardize on TetraGraph, as it sets a benchmark for others to follow. We are seeing strong momentum as hospitals across the US seek to comply with guidelines, reduce drug costs and improve patient safety. Our TetraGraph system has rapidly become the trusted solution of choice”, said Philip Siberg, CEO of Senzime.
The TetraGraph system helps anesthesiologists optimize and personalize dosing of both paralytic and reversal drugs, improving patient safety while reducing complications and costs. Each system generates recurring revenue using proprietary disposable sensors, creating a scalable and predictable business model for Senzime.
Today, TetraGraph is used in thousands of operating rooms worldwide. As more hospitals make the technology standard practice, Senzime continues to grow its market share at a large and underpenetrated market.